Skip to main content
Clinical Trials/CTRI/2022/05/042900
CTRI/2022/05/042900
Not yet recruiting
未知

Outcome of moderate mitral regurgitation in coronary artery disease patients undergoing elective coronary artery bypass grafting without mitral valve replacement.

fortis escorts heart institute0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I340- Nonrheumatic mitral (valve) insufficiency
Sponsor
fortis escorts heart institute
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
fortis escorts heart institute

Eligibility Criteria

Inclusion Criteria

  • Patients with moderate mitral regurgitation and coronary artery disease undergoing elective coronary artery bypass grafting.
  • Patients with informed written consent.

Exclusion Criteria

  • Patients with mitral regurgitation due to rheumatic, infectious, degenerative, congenital, papillary muscles rupture, elongated chordae tendineae.
  • Patients not giving informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials